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Abstract
Background: Transcranial direct current stimulation (tDCS) is used in human physiological studies and for
therapeutic trials in patients with abnormalities of cortical excitability. Its safety profile places tDCS in the pole-
position for translating in real-world therapeutic application. However, an episode of transient respiratory
depression in a subject receiving tDCS with an extracephalic electrode led to the suggestion that such an
electrode montage could modulate the brainstem autonomic centres.
We investigated whether tDCS applied over the midline frontal cortex in 30 healthy volunteers (sham n = 10, cath-
odal n = 10, anodal n = 10) with an extracephalic reference electrode would modulate brainstem activity as
reflected by the monitoring and stringent analysis of vital parameters: heart rate (variability), respiratory rate, blood
pressure and sympatho-vagal balance.
We reasoned that this study could lead to two opposite but equally interesting outcomes: 1) If tDCS with an extra-
cephalic electrode modulated vital parameters, it could be used as a new tool to explore the autonomic nervous
system and, even, to modulate its activity for therapeutic purposes. 2) On the opposite, if applying tDCS with an
extracephalic electrode had no effect, it could thus be used safely in healthy human subjects. This outcome would
significantly impact the field of non-invasive brain stimulation with tDCS. Indeed, on the one hand, using an extra-
cephalic electrode as a genuine neutral reference (as opposed to the classical “bi-cephalic” tDCS montages which
deliver bi-polar stimulation of the brain) would help to comfort the conclusions of several modern studies regard-
ing the spatial location and polarity of tDCS. On the other hand, using an extracephalic reference electrode may
impact differently on a given cortical target due to the change of direct current flow direction; this may enlarge
the potential interventions with tDCS.
Results: Whereas the respiratory frequency decreased mildly over time and the blood pressure increased steadily,
there was no differential impact of real (anodal or cathodal) versus sham tDCS. The heart rate remained stable
during the monitoring period. The parameters reflecting the sympathovagal balance suggested a progressive shift
over time favouring the sympathetic tone, again without differential impact of real versus sham tDCS.
Conclusions: Applying tDCS with an extracephalic reference electrode in healthy volunteers did not significantly
modulate the activity of the brainstem autonomic centres. Therefore, using an extracephalic reference electrode for
tDCS appears safe in healthy volunteers, at least under similar experimental conditions.
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Repetitive transcranial magnetic stimulation (rTMS) and
transcranial direct current stimulation (tDCS) can mod-
ulate brain excitability and behaviour in healthy volun-
teers [1,2]; numerous proof-of-principle studies have
demonstrated their therapeutic potential in patients with
disease resulting from or leading to abnormalities of
brain excitability such as Parkinson’s disease, stroke, tin-
nitus, chronic pain and depression [3-5]. Under different
forms and names, brain polarisation has been applied
extensively in human subjects since centuries (for an
extensive review, see ([6]). It is generally admitted that
the effects of tDCS are less focal than those of rTMS
and despite the development of realistic head models
uncertainties remain about the distribution of the direct
current (DC) within the brain. This issue is crucial since
it has been suggested that the current flow direction
relative to the neuronal elements may be one of the key
factors driving the effects of tDCS [7-13]. Interestingly,
an episode of transient respiratory depression in a
healthy volunteer under frontal tDCS with an extrace-
phalic reference electrode suggested that this electrode
montage could lead to a modulation of the brainstem
respiratory centres [14,15]. When Nitsche and Paulus
meticulously expanded the seminal findings of the
impact of tDCS on the primary motor cortex (M1)
excitability described by Priori and collaborators [16-18],
they cautiously banned the use of an extracephalic elec-
trode and proposed the now “classical” montage for
modulating M1 excitability with tDCS: the “active” elec-
trode over the target M1 and the other “reference” elec-
trode over the contralateral orbita [19].
Recently, some investigators applied tDCS with an
extracephalic reference electrode, without reporting
adverse events [20-24]. Accornero and collaborators con-
cluded that the use of an inion-neck montage did not
carry an extra risk since heart rate, blood pressure and
body temperature remained unchanged during tDCS and
20 minutes after in healthy volunteers [20]. However,
these conclusions were limited since the respiratory fre-
quency was not monitored and since the effects on the
autonomic nervous system were not explored.
Therefore, in order to explore whether tDCS with an
extracephalic reference electrode would modulate the
autonomic functions of the brainstem, respiratory fre-
quency, blood pressure and heart rate were continuously
monitored before, during and after tDCS in 30 healthy
volunteers. The vital parameters and parameters reflect-
ing the activity of the autonomic nervous system were
extracted and compared between the anodal, cathodal
and sham tDCS groups.
We reasoned that this study could lead to two oppo-
site but equally interesting outcomes:
1) Applying tDCS with an extracephalic electrode could
induce modulations of the vital parameters and/or in the
sympatho-vagal balance. Whereas the stimulation of the
brainstem by DC may appear at first sight as an unwanted
and potentially dangerous side effect, this might on the
other hand result in the development of an attractive new
tool to explore non-invasively the autonomic nervous sys-
tem in human subjects. The modulation of the activity of
the brainstem autonomic centres by tDCS may even open
new therapeutic perspectives. Indeed, the crucial role of
the autonomic nervous system in the regulation of the
major homeostatic functions has long been known [25,26].
Alternatively, targeting the cortical areas involved in the
control of the brainstem autonomic centres may also be
envisaged as a therapeutic intervention as suggested
recently [18]. Whether an indirect modulation of the
brainstem autonomic centres through cortical areas would
be more effective than a direct modulation of the brain-
stem by tDCS remains speculative.
2) On the opposite, if applying tDCS with an extrace-
phalic electrode had no effect on these parameters, it
could thus be used safely in healthy human subjects. This
outcome would significantly impact the field of non-inva-
sive brain stimulation with tDCS. Indeed, the use of an
extracephalic electrode as a genuine neutral reference (as
opposed to the bi-cephalic montage which deliver bi-
polar stimulation of the brain) would help to confirm the
conclusions of several modern tDCS studies using the
“bi-cephalic” tDCS montages regarding the importance
of DC flow direction, polarity, spatial location, and the
simultaneous stimulation of two brain regions by oppo-
site polarities. Whereas the measures of the cortical
excitability of M1 after tDCS are not influenced by a
“reference” electrode placed over the controlateral fron-
topolar cortex, the issue is much more debatable for cog-
nitive studies and studies using behavioural outcome
measures (reaction time, force, decision, etc.).
Methods
This exploratory study assumed a single-blind, sham-
controlled, parallel-group design. The 30 healthy volun-
teers were randomly assigned to receive a single 20-min-
utes session of anodal (n = 10), cathodal (n = 10) or
sham (n = 10) tDCS; they were tDCS-naïve and blinded
to the nature of the tDCS intervention.
Subjects
The protocol was approved by the local Ethical Com-
mittee (Comité d’éthique médicale des Cliniques univer-
sitaires UCL de Mont-Godinne, Yvoir, Belgium) and the
study was conducted according to the recommendations
of the Helsinki declaration. The 30 healthy volunteers
provided written informed consent at inclusion. The
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no known disease, 2) being between 20 and 60 years of
age. The exclusion criteria were 1) pregnancy, 2) pre-
sence of any chronic disease, 3) intake of drugs modu-
lating vital parameters (beta blockers, blood pressure
lowering drugs) or with a central action (antihistaminic,
antidepressant, antiepileptic), 4) presence of a pace-
maker or any intracranial metal. The three groups were
balanced for age and sex; demographic and characteris-
tics baseline heart rate, blood pressure are listed in
Additional file 1. The subjects were instructed to avoid
consuming caffeine, tea, alcohol or psycho-active drugs
since the day before the experiment. One female subject
in the cathodal group (# 14) was a regular smoker, she
avoided smoking overnight.
tDCS
Since the aim of the study was to detect whether tDCS
applied with an extracephalic electrode would modulate
the cardio-respiratory or autonomic functions at the
level of the brainstem, we used a montage comparable
to that used by Lippold and Redfearn [14,15], in order
to maximise the current flow through the brainstem,
except that a single electrode was applied over the scalp.
The active electrode (35 cm
2) was placed on the midline
over Fz and the extracephalic reference electrode (35
cm
2) was placed over the right tibia. tDCS electrodes
were soaked with a standard saline solution (NaCl 9%)
and maintained by elastic bands. An Eldith® DC-stimula-
tor (neuroConn GmbH, Ilmenau, Germany) delivered 20
minutes of anodal or cathodal stimulation (1 mA, fade
in/out 8 s). For sham stimulation, 30 s of stimulation
were applied (1 mA, fade in/out 8 s, 14 s on); the polar-
ity of the frontal electrode for the sham tDCS was ano-
dal in half of the healthy volunteers.
Before starting the 1-hour monitoring period, each
healthy volunteer was subjected to approximately 20 s
of tDCS (1 mA, fade in 8 s, 12 s on, manual termination
by the experimenter), in order to attenuate anxiety and
the novelty effect during the subsequent monitoring
period. Such stimulation is known to have only very
transient effect on cortical excitability [19]. By giving
this short tDCS stimulation, the subject were famil-
iarised with the cutaneous itching sensation before the
monitoring period and reassured about the benignity of
tDCS, thus minimising changes in heart rate, blood
pressure and respiratory frequency linked to anxiety.
After this short tDCS familiarisation, the monitoring
electrodes were placed, the experiment was re-explained
to the subject, calibrations and adjustments were per-
formed. Altogether, at least ten minutes elapsed between
the end of the brief tDCS familiarisation and the onset
of the 1-hour continuous monitoring period.
Monitoring
The 1-hour monitoring period was divided in three suc-
cessive epochs: baseline (20 minutes), intervention (20
minutes) and post-intervention (20 minutes). Monitor-
ing was performed in a quiet room with a dim light; the
room’st e m p e r a t u r ew a sk e p tc o n s t a n tt h r o u g h o u tt h e
monitoring period (22°C). After lying supine in a bed,
the subjects received the instruction to relax as much as
possible without falling asleep, to keep a regular self-
paced respiratory frequency and to avoid talking. They
were kept awake by the investigators who continuously
talked to them and checked their wakefulness state, as
well as the appearance of any discomfort. In some occa-
sions, the subjects were allowed to talk briefly in order
to avoid falling asleep. On-line monitoring of the vital
parameters was performed by visual inspection of the
displayed data and trends.
Respiratory frequency (RF, Hz) monitoring was per-
formed through a piezo-electric sensor (Sleepmate®,
Ambu Inc, Maryland, United States) mounted on an
adjustable elastic belt positioned over the xiphoid pro-
cess. Digital markers were used to define the start of
tDCS, end of tDCS, and any events during the monitor-
ing period. The respiratory waveform was recorded with
a conventional multichannel EEG system (Brainnet®
MEDATEC, Brussels, Belgium), filtered (0.18 Hz -
16 Hz), with a 200 mV gain. During off-line analysis,
the respiratory frequency (Hz) was manually edited over
periods of 30 seconds which were then concatenated in
5 minutes bins for statistical analysis.
Continuous monitoring of blood pressure and heart
rate was performed with a Task Force® Monitor 3040i
(CNSystems Medizintechnik GmbH, Graz, Austria).
Blood pressure (mmHg) was continuously monitored at
the index or third finger of the right hand with a special
finger cuff, alternating between the index and third fin-
ger cuff when subject mentioned discomfort (verbally
checked every five minutes). A control oscillometric
measure of the blood pressure (mmHg) was performed
every five minutes through a standard blood pressure
cuff placed on the left arm. The Task Force Monitor
V2.1 software allows the continuous monitoring and
recording of beat-to-beat systolic (sBP) and diastolic
(dBP) blood pressure.
Continuous heart rate (HR) monitoring in beat per
minute (bpm) was performed through four surface elec-
trodes placed on the deltoid muscles and over the
twelfth ribs along the median axillar line on both sides.
The ground electrode was placed on the left leg. The
Task Force® Monitor was synchronised with the Brain-
Net® respiratory monitoring system; digital markers
(onset of tDCS, end of tDCS) were simultaneously
added to both systems to ensure synchronicity.
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extracted for statistical analysis: the heart rate (HR, in
bpm), the systolic (sBP) and diastolic (dBP) blood pres-
sures (mmHg). In order to evaluate the sympathetic and
parasympathetic tones, power spectra analysis of the R-
R interval (RRI) were brought into the frequency
domain by the adaptive autoregressive parameter algo-
rithm implemented in the Task Force Monitor V2.1
software. The sympathetic and vagal tones of the human
autonomic nervous system can be estimated from power
spectra analysis of heart rate variability (HRV) [27-32].
The sympathetic tone is reflected by the low frequency
band (LF-band: 0.04-0.15 Hz) of the HRV, whereas the
vagal tone is reflected by the high frequency band (HF-
band: 0.15-0.4 Hz) partly contaminated by the RF
(respiratory sinus arrhythmia, RSA) [28,32]. The follow-
ing parameters were computed and extracted for off-line
statistical analysis: LF nu-RRI (sympathetic tone of RRI
in normalised unit (nu), %), HF nu-RRI (vagal tone of
RRI in normalised unit (nu), %), LF/HF-RRI (sympatho-
vagal balance of RRI), and PSD-RRI (Power Spectral
Density of RRI, ms
2). The number of ectopic beats by
epoch was counted separately for each subject.
Statistical analysis
Statistical analyses were performed using the SPSS® 15.0
statistical software (SPSS Inc., Chicago, Ill). First, in
order to disclose gross changes between epochs and
types of stimulation, a repeated measures analysis of
variance (ANOVARM) was performed by the multivari-
ate procedure and T
2 Hotelling test to compare the
mean and SD values of each group and each epoch
(baseline, intervention, post-intervention).
Then, the mean and SD values of each parameter were
concatenated in bins of 5 minutes and compared in
order to detect potential changes within and between
the epochs. These 5 minutes bins of the mean and SD
values were analyzed by regression of repeated measures
using generalized estimating equations (GEE) to take
into account the multiplicity of inter-correlated values
in each subject [33]. GEE models used a normal prob-
ability distribution, an identity link function and an
exchangeable working correlation matrix structure. A
first GEE model compared the baseline epochs of the 3
groups to rule out baselines differences between groups,
which would prompt to compute GEE analysis sepa-
rately for each group. A second GEE model used sex,
age, group, epoch and an interaction term epoch-group
as covariates with respect to the baseline epoch consid-
ered as common for the 3 groups after the use of the
first model. Since this study was designed for exploring
the potential of tDCS with an extracephalic reference
electrode to modulate the activity of the brainstem auto-
nomic centres, we intentionally decided to avoid using
corrections for multiples comparisons such as Bonfer-
roni correction.
Finally, the percentages of parameters values outside
the limits defined by the mean ± 1.96 SD computed on
the baseline values of each subject were also considered.
They were compared between groups by Kruskal-Wallis
analysis of variance by ranks for each parameter and
each epoch, and between phases by Friedman test for
each parameter and each group.
Results
Apart from transient itching sensation under the tDCS
electrodes in several subjects, the unique side-effect
reported was the occasional perception of phosphenes
during the ramp in of tDCS (n = 2). Whereas phos-
phenes have never been reported using a ramping up
current, defective electrode contact is ruled out by the
fact that no error message was provided by the Eldith
DC stimulator®. We can only speculate that this elec-
trode montage may be particularly prone to induce
phosphenes. It is also worth noting that the occurrence
of phosphenes was explicitly mentioned before familiari-
sation as a potential side effect in order to avoid exces-
sive stress reaction; some subjects may have been
particularly receptive to suggestion or attentive to visual
effects. None of the subject reported discomfort, breath-
ing difficulty or palpitation; there was no drop-out. Dur-
ing the experiment, no change was observed by on-line
monitoring for any of the parameters of interest.
Using one value per 20-minutes epoch (baseline, tDCS,
post-tDCS) per subject, the ANOVARM failed to disclose
any statistically significant overall difference for the
means and SDs of any parameters between groups. How-
ever, the ANOVARM showed a significant effect of
epochs, with a decrease in the RF (p < 0.001, see Figure
1), not significantly different between groups (p = 0.805).
Similarly, there was an increase in the mean sBP (p <
0.001) and dBP (p = 0.001), as depicted in Figure 2.
Whereas the mean and SD HR remained stable (p =
0.960 and 0.854, respectively; see Figure 2), there was an
increase in the mean LF nu-RRI and a mirroring decrease
in the mean HF nu-RRI (p = 0.001); a consequent
increase in the mean PSD-RRI (p = 0.031) and in the LF/
HF ratio (p = 0.022). There was neither a statistically sig-
nificant difference between groups (all p > 0.137) nor any
significant group by epoch interaction (all p > 0.141).
Hence, whereas the parameters changed gradually over
time, these changes were similar between groups.
As estimated by the first GEE model, baseline data for
the three groups were not statistically different when
comparing the mean and SD values of the following
parameters: RF, HR, sBP, dBP, PSD-RRI and the LF/HF-
RRI ratio (all p values > 0.143). Whereas the mean LF
nu-RRI and HF nu-RRI baselines were not statistically
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nu-RRI) of the sham group were significantly smaller
than in the anodal (p = 0.020) and lower than in the
cathodal (p = 0.068) groups, which prompted to com-
pute separate GEE models for each group.
Then, age, sex, group, epoch and interaction epoch-
group were used as covariates in the second GEE regres-
sion in order to search for more subtle changes between
the mean and SD values of the parameters of interest.
In accordance with the global ANOVARM,t h es e c o n d
GEE model showed that the RF decreased significantly
and steadily throughout the monitoring period (p =
0.021), without significant difference between groups
(p = 0.561) nor group by epoch interaction (p = 0.459).
Sex also influenced the RF since the RF was lower in
male than in female subjects (p = 0.033).
The mean sBP and dBP increased significantly over
time (p = 0.010 and 0.001, respectively, see Figure 1);
Figure 1 Temporal evolution of the RF for each group (sham, cathodal, anodal). Mean +/- 1 SD of the RF by bins of 5 minutes over the
monitoring period (3 epochs: baseline, tDCS, post-tDCS).
Figure 2 Temporal evolution of the sBP and HR for each group (sham, cathodal, anodal). Mean +/- 1 SD of the RF by bins of 5 minutes
over the monitoring period (3 epochs: baseline, tDCS, post-tDCS).
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itoring period was not different between groups (p >
0.28) and there was no significant group by epoch inter-
action (p > 0.55). Age and sex significantly impacted
blood pressure: the mean sBP was higher in younger
than in older subjects (p = 0.006) and also higher in
male than in female subjects (p < 0.001); the SD of the
sBP was larger in older than in younger subjects (p =
0.048). The mean dBP was higher in male than in
female subjects (p < 0.001), whereas the SD of the dBP
was larger in female than in male subjects (p = 0.044).
The mean and SD of the HR did not change signifi-
cantly over time and seemed not influenced by group,
age or sex (all p > 0.093, Figure 1). Whereas ANOVARM
demonstrated a significant global effect of epoch on the
LF nu-RRI and HF nu-RRI, the GEE model showed only
a non-significant trend for an increase of the mean LF
nu-RRI and a mirror decrease of the mean HF nu-RRI
(p = 0.056) over the monitoring period. In addition, the
GEE model also disclosed a significant overall effect of
group (sham group with a lower mean LF nu-RRI and a
higher mean HF nu-RRI than the anodal and cathodal
groups, p = 0.026). However, there was no significant
group by epoch interaction (p = 0.584). Since the base-
line SD values of the LF nu-RRI and HF nu-RRI were
statistically different, separate GEE models were com-
puted for each group; these separate GEE models
showed no significant effect for the sham and anodal
groups (p > 0.277) but showed a significant decrease
(increase) of the SD values for the LF nu-RRI (HF nu-
RRI) over time for the cathodal group only (p = 0.044).
Again, whereas ANOVARM seemed to demonstrate a
significant global effect of epoch suggesting an increase
of the PSD-RRI and LF/HF ratio, the GEE model failed
to find any significant effect of phase, group, age, sex
nor group by epoch interaction (all p > 0.101) for the
mean and SD values of the PSD-RRI and LF/HF ratio.
Infrequent ectopic beats were observed in only two
healthy volunteers (# 9 and #19); these ectopic beats
were randomly distributed throughout the epochs.
Finally, the percentages of values outside the mean ±
1.96 SD did not differ significantly between the three
groups for any parameter and any epoch. There was a
trend for an increase of these percentages between
epochs 1, 2 and 3, which was significant for sBP and
d B Pi nt h et h r e eg r o u p s( p=0 . 0 0 3a n dp=0 . 0 1 4
respectively), for PSD-RRI in the cathodal group (p =
0.020) and for LF/HF-RRI in the cathodal (p = 0.027)
and anodal (p = 0.007) groups.
Discussion
Thirty healthy volunteers were subjected to 1 mA tDCS
during 20 minutes with a mid-line frontal electrode
(anodal n = 10, cathodal n = 10, sham n = 10) and an
extracephalic reference electrode, under continuous car-
dio-respiratory monitoring. No adverse effect was
observed. While the RF decreased progressively, the
blood pressure increased steadily over time, without sig-
nificant difference between groups. The HR remained
stable during the monitoring period. The HRV para-
meters reflecting the tones of the sympathetic and vagal
autonomic nervous system suggested a progressive shift
in the sympathovagal balance favouring the sympathetic
tone. Neither anodal nor cathodal tDCS modified the
sympathovagal balance when compared to sham tDCS.
tDCS and the brainstem
Lippold and collaborators reported an episode of dis-
turbed speech and apnoea followed by a transient
respiratory depression in a normal female subject who
received 16 minutes of 3 mA bi-frontal cathodal tDCS,
with an extracephalic reference electrode [14,15]. The
authors concluded that the respiratory depression was
d u et oa nu n w a n t e dm o d u l a t i o no ft h eb r a i n s t e m
respiratory centres by the DC flowing through the
brainstem [14,15]. Recently, tDCS with an extracephalic
reference electrode has been safely applied using various
montages: inion and neck base [20], M1 and ipsilateral
shoulder ([21] and in two patients with Tourette syn-
drome [22], left fronto-temporal areas or inion and right
shoulder [22], bi-frontal and non-dominant arm [23],
bilateral dorsolateral prefrontal cortex and right deltoid
[34], cerebellum [35]. However, monitoring of the
respiratory frequency or exploration of subtle changes in
the sympathovagal balance have not been conducted so
far, leaving unanswered the issue whether tDCS could
modulate the activity of the brainstem autonomic ner-
vous nuclei.
If tDCS with an extracephalic reference electrode
could modulate the activity of the brainstem cardio-
respiratory and autonomic centres, this would lead to
the exciting possibility to directly test and manipulate
homeostatic functions such as respiratory frequency,
heart rate. Moreover, this could lead to therapeutic per-
spectives since the autonomic nervous system is an
essential target for pharmacological therapies given its
key role in hypertension, heart failure, cardiac arrhyth-
mias, sudden death or dysrhythmic breathing [36-39].
Respiratory frequency
In the present experiment, the extracephalic reference
electrode was placed on the right leg and a unique
active tDCS electrode over Fz, to maximise the likeli-
hood of orienting the DC flow through the brainstem.
The RF decreased steadily throughout the 1-hour moni-
toring. This mild diminution of the RF could be
explained by a progressive relaxation while lying supine.
When necessary, the healthy volunteers were allowed to
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minutes of monitoring. Although this may partly explain
the decrease of the measured RF in the three groups,
this trend was present since the onset of the monitoring
period. Nevertheless, there was no significant difference
in the temporal evolution of the RF between the sham,
anodal and cathodal groups. Therefore, 20-minutes of
tDCS applied with an extracephalic reference electrode
seem not to interfere with the activity of the brainstem
respiratory network and thus appear to be safe in
healthy volunteers. Of course, longer stimulation peri-
ods, higher tDCS intensities, other electrode montages
and the inclusion of patients should be performed
before this conclusion can be generalised.
Blood pressure
The blood pressure increased mildly throughout the
monitoring period from the onset of the experiment,
suggesting an increasing nervousness during the moni-
toring period rather than transient anxiety at the onset
of intervention. This hypothesis is supported by the fact
that the HR remained stable over time (see below). The
blood pressure remained within the normal range for
most of the healthy volunteers during the baseline
epoch; some of them showed values compatible with
previously unknown mild hypertension, mostly by the
end of the monitoring period. The variability outside the
mean ± 1.96 SD also increased throughout the epochs
in all three groups. Anyway, the blood pressure followed
a similar temporal evolution in the three groups.
Heart rate and sympathovagal balance
The HR remained stable over time in the three groups,
ruling out transient stress at the onset of intervention or
a significant effect of tDCS on HR. There was a signifi-
cant increase of the LF nu-RRI and a mirroring decrease
of the HF nu-RRI over time, as well as resulting
increases in the LF/HF ratio and PSD-RRI. These pro-
gressive changes were similar for the three groups, sug-
gesting a progressive shift of the sympathovagal balance
in favour of the sympathetic tone.
Could this shift of in the power of the LF and HF
bands have been driven by the decline of RF? Indeed,
whereas the HF band of HRV reflects the vagal tone, it
is also partly contaminated by the RF, a phenomenon
called the respiratory sinus arrhythmia (RSA) [28,32].
Tasks such as mental arithmetic test or free talking may
shift respiration and the HRV balance within the LF
band [40]. In the present experiment, whereas the RF
decreased mildly over time, the LF nu-RRI increased.
However, since the R-R variability is almost abolished
after autonomic ganglion blockade of both the sympa-
thetic and parasympathetic nervous systems in healthy
volunteers during supine resting condition, it has been
suggested that the HRV is predominantly mediated by
the autonomic nervous system [31]. Overall, there was a
progressive shift of the sympathovagal balance in favour
of the sympathetic tone, similar in the three groups,
likely reflecting an increasing nervousness. It is of
course acknowledged that the concept of sympathovagal
balance is a coarse approximation and does not fully
reflect the complex interactions of the sympathetic and
vagal systems [28,32,41]
In addition, the GEE model disclosed subtle differ-
ences that were not picked up by the ANOVARM.T h e
LF nu-RRI was lower (and the HF nu-RRI higher) in the
sham group than in both the anodal or cathodal group
but, again, there was no epoch by group interaction.
Similarly, the percentage of data outside the mean ±
1.96 SD increased for the LF/HF-RRI ratio in the anodal
and cathodal groups. In order to explain this difference
between the sham group on the one hand and the ano-
dal and cathodal groups on the other hand, one should
hypothesize that both anodal and cathodal tDCS
induced the same changes in the sympathovagal balance
whereas sham intervention had no influence. This
would imply that the DC “interfered” with the activity of
these brainstem centres independently of its flow direc-
tion, resulting in the same net effect. Alternatively,
whereas subjects undergoing tDCS are unable to expli-
citly point out whether the tDCS stimulation is on
(active) or off (sham) [42], they still may unconsciously
perceive the active stimulation and experience sublim-
inal stress. This would hold true only if this change
started after the onset of intervention; however it was
already present during the baseline period and built-up
steadily.
The separate GEE models disclosed a decrease in both
the LF nu-RRI and HF nu-RRI variability exclusively in
the cathodal group; this was reflected in the fact that
the analysis of the percentage of variance outside the
mean ± 1.96 SD also showed a difference for the PSD-
RRI for the cathodal group only. This isolated result is
difficult to interpret since theb a s e l i n ed i f f e r e n c et h a t
prompted to compute separate GEE models concerned
the sham group versus the anodal and cathodal group.
Asymmetry of the DC flow
Could the 1964 episode of respiratory depression [14,15]
result from an asymmetrical distribution of the DC
within a specific part of the brainstem or on its right
aspect (the extracephalic electrode was on the right leg)?
Lateralised tDCS with an extracephalic electrode could
theoretically impact on cardio-respiratory homeostasis
through three additional mechanisms. First, when
applied over the lateral aspect of the head, the DC could
potentially modulate the activity of the cortical areas
involved in the control of autonomic nervous functions
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debate about the hemispheric lateralisation of auto-
nomic control in human is still open [45], the insula
and parietal cortices may be particularly important in
the control of heart rate and have been involved in sud-
den cardiac death and cardiac arrhythmia after stroke
[39,46,47].
Second, since DC can modulate the excitability of per-
ipheral nerves [48], the DC flowing preferentially
through the lateral aspect of the neck could theoretically
interfere with the vagus nerve excitability. It is worth
noting that the right vagus nerve seems conveying a pre-
dominant outflow toward the heart [49]. Recently, two
out of three patients receiving right vagus nerve stimula-
tion for refractory epilepsy suffered from respiratory
events suggestive of bronchoconstriction [50]. Therefore,
i tc a n n o tb er u l e do u tt h a te p i s o d eo fr e s p i r a t o r y
depression under tDCS with a right extracephalic elec-
trode [14,15] was due to a modulation of the right vagus
nerve excitability, resulting in breathing difficulties.
Third, the phrenic nerve might also be influenced by
DC, maybe leading to a modulation of the RF and
respiratory depression. However, whereas unilateral
paralysis of the phrenic nerve may result in hemidiaph-
ragmatic paralysis leading to severe respiratory compli-
cations [51,52], a stunning of the phrenic nerve is
speculative.
Cephalic and extracephalic tDCS reference electrode
The modern safety guidelines for tDCS [53] recommend
using bi-cephalic montages, which have the obvious
advantage of avoiding any stimulation of the brainstem
but introduce an ambiguity: are the observed effects
exclusively due to modulation of the target cortical area
activity or to the combination of the modulation of the
target area and of the contralateral cortex located under
the so-called “reference” e l e c t r o d e ?I ti so n l yr e c e n t l y
that this issue was partly resolved by using a large
“reference” electrode placed over the contralateral orbita
[54]. Since this large electrode is theoretically neutral
(the current under the large electrode is so dispersed
that it should be ineffective), the effects observed could
be attributed solely to the modulation of the target M1
by a small “active” electrode.
Nevertheless, using an extracephalic reference elec-
trode could lead to two opposite but equally interesting
conclusions. On the one hand, if the direction of the
DC flow is a key factor determining the (after-)effects of
tDCS as suggested by recent modelling studies [7-13],
then using an extracephalic reference electrode may
potentially expand the variety of potential interventions
with tDCS.
On the other hand, the impact of tDCS on a given
cortical target may be insensitive to the DC flow
direction, whether a cephalic or an extracephalic refer-
ence electrode is used. Therefore, using an extracephalic
electrode as a genuine neutral reference would help to
substantiate the conclusions of several recently pub-
lished tDCS studies with bi-cephalic montages regarding
the spatial location of the observed tDCS effects.
Whereas the measures of the cortical excitability of M1
after tDCS are not influenced by a “reference” electrode
placed over the controlateral frontopolar cortex, the
issue is much more debatable for cognitive studies or
studies using behavioural outcome measure. As long as
behavioural studies are concerned, the definition of a
cortical area as “functionally inert for the relevant task”
for a control experiment may be questioned. These con-
trol experiments are of course of paramount importance
but their interpretation may not be as straightforward as
commonly accepted.
Limitations of the study
Several issues should be taken in account when evaluat-
ing the outcomes of the present experiment. Firstly,
whereas bi-frontal electrodes were used by Lippold and
collaborators [14,15], in this experiment, a single cepha-
lic electrode was placed on Fz in order to maximise the
chance of directing the DC flow towards the brainstem.
Moreover, during pilot experiences, positioning the
cephalic electrode more anteriorly (i.e. over FPz)
induced a typical metallic taste in the mouth in most
subjects, which raised concerns for the double-blind
character of the experiment.
Secondly, as already mentioned, the intensity of the
DC was much larger in the study of Lippold et al
[14,15] (16 minutes of 3 mA bi-frontal cathodal tDCS);
this may explain the lack of effect observed in the pre-
sent experiment. However, we deliberately decided to
apply 20 minutes of 1 mA tDCS because 1) these para-
meters were used in the majority of the modern tDCS
studies, 2) the blinding of healthy subjects is question-
able when using high tDCS intensities such as 3 mA
(tingling and itching cutaneous sensations), and 3) this
study was designed as a first step towards other experi-
ments exploring different parameters (larger cohorts of
healthy volunteers, higher tDCS intensities, different
locations of the cephalic electrode, inclusion of
patients).
Conclusions
Although this comprehensive study expands and con-
firms recent reports suggesting a lack of interference of
tDCS with an extracephalic reference electrode with
vital functions [20-23,34,35], it has several limitations.
First, as discussed previously, only a midline frontal -
right lower limb montage was explored, leaving unan-
swered the question whether tDCS applied on lateral
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parietal cortices) could modulate vital parameters or
autonomic nervous functions. Second, since only healthy
volunteers were included in this exploratory study, the
conclusions may not apply to patients with brain or car-
diovascular diseases. Third, whereas 20 minutes of tDCS
at 1 mA has been used in most of the physiological stu-
dies, higher intensities, longer durations and repeated
intervention should be tested in order to establish the
safety of this montage.
A conservative interpretation of the present results
would suggest that, using the same electrode montage
and tDCS parameters, interference of tDCS with an
extracephalic reference electrode at the level of the
brainstem should be rather limited if any, and can be
considered as safe in healthy volunteers. Further
experiments are warranted to verify whether this con-
clusion may be extended to other tDCS parameters
(electrodes montage, intensity, duration, etc) and to
patients. Therefore, the use of an extra-cephalic refer-
ence electrode in future tDCS studies would expand
the field of tDCS experiments by allowing to test dif-
ferent DC flow direction or help to confirm the con-
clusions of several modern tDCS studies regarding the
spatial location and the real impact of concomitant bi-
polar stimulation of different parts of the brain as
inherently provided by bi-cephalic tDCS montages.
Since tDCS have several features that place it in the
pole-position to succeed in the translation from bench
to bedside for therapeutic use in the real world, the
safety aspect and potentially differential physiological
effect of tDCS with an extracephalic electrode requires
further investigations.
Additional file 1: Demographics and baseline data (mean ± SD).A s
can be appreciated from the Additional file, the three groups were
balanced for age and sex; demographic and characteristics baseline heart
rate, blood pressure are also provided for each subject. BMI: body mass
index, RF: respiratory frequency, sBP(dBP): systolic(diastolic) blood
pressure, HR: heart rate, LF(HF) nu-RRI: low (high) frequency band of RRI
in normalised unit, PSD-RRI: Power Spectral Density of RRI, LF/HF RRI: LF/
HF ratio of RRI.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2202-11-
38-S1.DOC]
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